The dividend capture strategy is an income-focused stock trading strategy popular with day traders. In contrast to traditional approaches, which center on buying and holding stable dividend-paying stocks to generate a steady income stream, it is an active trading strategy that requires frequent buying and selling of shares, holding them for only a short period
0 Comments
We have seen a number of new thematic ETFs launched this year. Some of them make sense and some don’t. But here’s a new ETF that provides investors a convenient way to profit from a new industry with massive growth potential. Mobileye: https://www.zacks.com/stock/quote/MBLY?cid=CS-YOUTUBE-FT-VID Cisco Systems: https://www.zacks.com/stock/quote/CSCO?cid=CS-YOUTUBE-FT-VID Skyworks Solutions: https://www.zacks.com/stock/quote/SWKS?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow
0 Comments
History has repeatedly shown that market crashes are almost a “natural” part of the investing cycle. On July 19, the S&P 500 saw its worst single-session plunge in months, fueling speculation that a major correction might be around the corner — and that will provide stocks to buy. The spread of the delta variant, which
0 Comments
In this article UIS SPG TTWO Shoppers ascend and descend escalators at the King of Prussia Mall, owned by Simon Property Group, United State’s largest retail shopping space, in King of Prussia, Pennsylvania. Mark Makela | Reuters Check out the companies making headlines after the bell:  Take-Two Interactive Software — The video game company saw
0 Comments
Bionano (NASDAQ:BNGO) is a small life sciences company. Biotech companies use Bionano’s Saphyr system for researching DNA and to diagnose illnesses caused by genetics. Up until recently, Bionano has had difficulty achieving widespread market adoption for Saphyr. However, BNGO stock has gone on a wild ride over the past year as traders gravitated to Bionano’s
0 Comments
At one point, Zomedica (NYSE:ZOM) could do no wrong. ZOM stock would explode some 2,900% from its November 2020 lows. The company was nearing commercialization of its point-of-care diagnostic product. Even the pet industry was howling about the opportunity. Source: Postmodern Studio / Shutterstock.com Nowadays, Zomedica has become a slow-motion train wreck. In fact, the last
0 Comments
The company that catapulted the e-commerce revolution, Amazon (NASDAQ:AMZN) hardly needs any help doing what it does best: dominating whatever market it decides to disrupt next. Yet the novel coronavirus pandemic proved that at least from a shareholder’s perspective, AMZN stock is not above receiving assistance from fortuitously aligned events. Source: Julie Clopper / Shutterstock.com
0 Comments
In 2019, China banned initial coin offerings. In 2021, according to Reuters, the country stepped up its crackdown on cryptocurrency by banning financial institutions and payment companies from providing cryptocurrency transaction services and warned investors against speculative crypto trading. These were attempts by China to clamp down on the digital trading market. Considering this anti-crypto
0 Comments
On today’s show, Preston and Stig talk to former billion dollar hedge fund manager, Jesse Felder. Jesse provides valuable insights into the market expectations for 2019. IN THIS EPISODE, YOU’LL LEARN: – Why Warren Buffett’s valuation metric for the stock market forecasts around a 0% return over the next 10 years – Why Warren Buffett
0 Comments
Other than a short-lived rally in June fueled by Reddit users, ContextLogic (NASDAQ:WISH) stock is on a permanent trajectory downward. Source: sdx15 / Shutterstock.com WISH stock peaked at $32.85, shortly after its initial public offering earlier this year. The company’s unfavorable valuations, mixed first-quarter results, and poor sales forecast continue to weigh on its share
0 Comments